New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older Business Wire Source link
Cohort studies on 71 outcomes among people with atopic eczema in UK primary care data Nature.com Source link
LEO Pharma Presents Prevalence, Severity, and Treatment CHECK Data for Chronic Hand Eczema Dermatology Times Source link